Ligand-binding Assay Validation

Ligand-Binding Assay Validation is the systematic process of confirming that a ligand-binding assay, which quantifies analytes through specific molecular interactions such as antigen-antibody binding, performs with established accuracy, precision, sensitivity, and reliability for its intended bioanalytical use.

205

Publications

12.5K

Citations

1.3K

Authors

380

Institutions

Publications per year

2017–2026

30

Authors

1.3K

  1. GJ
    Gregor Jordan

    Roche Pharma AG (Germany), Germany

    4 publications · 52 citations

    4

    h-index

  2. BD
    Binodh DeSilva

    Bristol-Myers Squibb (United States), United States

    4 publications · 706 citations

    4

    h-index

  3. AN
    Alex N. Eberlé

    University Children’s Hospital Basel, Switzerland

    4 publications · 332 citations

    4

    h-index

  4. RF
    Roland F. Staack

    Roche Pharma AG (Germany), Germany

    4 publications · 52 citations

    4

    h-index

  5. AJ
    Alison Joyce

    Pfizer (United States), United States

    4 publications · 71 citations

    4

    h-index

1–5 of 1.3K

Venues

  1. Bioanalysis

    BIO · 25 publications · 615 citations

    14

    h-index

  2. Journal of Medicinal Chemistry

    12 publications · 633 citations

    12

    h-index

  3. Analytical Biochemistry

    11 publications · 964 citations

    11

    h-index

  4. The AAPS Journal

    AAPSJ · 10 publications · 722 citations

    10

    h-index

  5. The Journal of Clinical Endocrinology & Metabolism

    JCEM · 7 publications · 608 citations

    7

    h-index

1–5